国家肺癌筛查登记中阳性筛查结果比国家肺癌筛查试验更常见
该回顾性研究比较了ACR肺癌筛查登记(LCSR)与国家肺癌筛查试验(NLST)的基线低剂量胸部CT的Lung-RADS评分,LCSR纳入686,011人、NLST纳入26,432人;调整年龄、性别、吸烟史和体质指数后,LCSR人群Lung-RADS 2、3、4A、4B、4X相对于1的校正比值比及95%CI均大于1,提示临床筛查中Lung-RADS评分高于NLST。
要点
- 临床筛查登记LCSR的Lung-RADS评分高于NLST,调整混杂因素后仍如此。
- LCSR人群较NLST更年长、女性更多、当前吸烟者更多。
- LCSR相对NLST,Lung-RADS 2、3、4A、4B、4X相对于1的校正OR均大于1。
核心结论
- 临床肺癌筛查中的Lung-RADS评分高于NLST,即使调整年龄和吸烟等已知混杂因素后仍如此,可能意味着临床筛查人群筛查后随访检查率更高、潜在癌症率更高。
研究设计与样本
- 回顾性研究,纳入LCSR基线低剂量胸部CT 686,011例和NLST基线低剂量胸部CT 26,432例,NLST结果重新编码为Lung-RADS 1.1版,采用多变量多项logistic模型分析。
诊断标准与关键数值
- LCSR相对NLST,Lung-RADS 2、3、4A、4B、4X相对于Lung-RADS 1的校正比值比及95%CI均大于1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Although lung cancer screening (LCS) with low-dose chest CT (LDCT) is recommended for high-risk populations, little is known about how clinical screening compares with research trials. We compared Lung CT Screening Reporting and Data System (Lung-RADS) scores between a nationally screened population from the ACR's LCS Registry (LCSR) and the National Lung Screening Trial (NLST).
METHODS: This retrospective study included baseline LDCT examinations from the LCSR and NLST. Patient characteristics (age, gender, smoking status, pack-years, and body mass index) were obtained. NLST LDCT results were recoded to Lung-RADS version 1.1. A multivariable multinomial logistic model was used to examine variations in Lung-RADS scores by screening group (LCSR versus NLST) and patient characteristics.
RESULTS: In all, 686,011 and 26,432 participants from the LCSR and NLST, respectively, were included. Compared with the NLST, the LCSR population was older (mean age [SD]: 64.0 [5.4] versus 61.4 [5.0] years); P < .001) and included more female patients (47.9% versus 40.9%; P < .001), and its patients were more likely to be currently smoking (61.5% versus 48.1%; P < .001). After adjusting for age, gender, smoking history, and body mass index, the LCSR population was more significantly likely to have higher Lung-RADS scores than the NLST (adjusted odds ratio and 95% confidence interval > 1 for Lung-RADS scores 2, 3, 4A, 4B, 4X relative to Lung-RADS 1).
CONCLUSIONS: Lung-RADS scores in clinical LCS are higher than in the NLST, even after adjusting for known confounders such as age and smoking. This would imply higher rates of follow-up testing after LCS and potentially higher cancer rates in the clinically screened population than the NLST.
引用
- Tailor TD, Gutman R, An N, et al. Positive Screens Are More Likely in a National Lung Cancer Screening Registry Than the National Lung Screening Trial. J Am Coll Radiol. 2025. PMID: 40023436. doi:10.1016/j.jacr.2025.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。